[1]陈雁君,刘求红,刘红.基于网络药理学的复方血栓通胶囊治疗视网膜静脉阻塞机制研究[J].西部中医药,2024,37(01):88-94.[doi:10.12174/j.issn.2096-9600.2024.01.18]
　CHEN Yanjun,LIU Qiuhong,LIU Hong.The Mechanism of Compound Xueshuantong Capsules in the Treatment of Retinal Vein Occlusion Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2024,37(01):88-94.[doi:10.12174/j.issn.2096-9600.2024.01.18]
点击复制

基于网络药理学的复方血栓通胶囊治疗视网膜静脉阻塞机制研究
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年01期
页码:
88-94
栏目:
二次研究
出版日期:
2024-01-15

文章信息/Info

Title:
The Mechanism of Compound Xueshuantong Capsules in the Treatment of Retinal Vein Occlusion Based on Network Pharmacology
作者:
陈雁君1, 刘求红2, 刘红2
1.广州中医药大学第一临床医学院，广东 广州 510405
2.广州中医药大学第一附属医院眼科，广东 广州 510405
Author(s):
CHEN Yanjun1, LIU Qiuhong2, LIU Hong2
1.First Clinical Medicine School, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
2.Ophthalmology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, China
关键词:
视网膜静脉阻塞; 网络药理学; 复方血栓通胶囊
Keywords:
retinal vein occlusion; network pharmacology; compound capsules
分类号:
R276.7
DOI:
10.12174/j.issn.2096-9600.2024.01.18
文献标志码:
A
摘要:
目的基于网络药理学方法探究复方血栓通胶囊治疗视网膜静脉阻塞（retinal vein occlusion，RVO）的潜在作用靶点及机制。 方法利用中药系统药理学数据库与分析平台（traditional Chinese medicine systems pharmacology database and analysis platform，TCMSP）获取三七、黄芪、丹参、玄参的活性成分及相关靶点。运用GeneCards、在线孟德尔人类遗传数据库（online mendelian inheritance in man，OMIM）以及DrugBank数据库获取RVO的相关作用靶点，采用Cytoscape 3.7.2软件绘制“疾病-药物-活性成分-靶点”图，借助STRING数据库建立靶点蛋白-蛋白互作网络（protein-protein interactions，PPI），并挖掘其中潜在的蛋白质功能模块。最后通过Metascape平台进行基因本体论功能（gene ontology，GO）富集分析和京都基因与基因组百科全书（kyoto encyclopedia of genes and genomes，KEGG）富集分析。 结果筛选得到复方血栓通胶囊119个有效活性成分，有效靶点202个，RVO的疾病靶点1539个，最终获得复方血栓通胶囊治疗RVO有效靶点115个，通过PPI筛选出主要核心靶点10个，富集分析得到的有效靶点主要参与癌症相关通路，糖尿病并发症相关AGE-RAGE、流体剪切应力与动脉粥样硬化、白细胞介素17、肿瘤坏死因子、PI3K-Akt、MAPK等信号通路。 结论复方血栓通胶囊主要通过调节氧化应激、炎症因子、新血管生成、细胞凋亡等过程治疗RVO。
Abstract:
ObjectiveTo dig out the potential targets and mechanism of compound Xueshuantong capsules in the treatment of retinal vein occlusion (RVO) based on network pharmacology method. MethodsThe active ingredients and the targets of Sanqi (Notoginseng Radix Et Rhizoma), Huangqi (Astragali Radix), Danshen (Salviae Miltiorrhizae Radix Et Rhizoma) and Xuanshen (Scrophulariae Radix) were yielded by utilizing TCMSP platform. RVO-related targets were obtained by using GeneCards, OMIM and DrugBank, the diagram of "disease-medicine-active ingredients-targets" was constructed by using Cytoscape 3.7.2 software, protein-protein interactions (PPI) network diagram of the targets were established by String database, to unearth the potential protein function module. Consequently, Gene Ontology functional enrichment analysis and KEGG were performed by Metascape platform. ResultsVia screening, 119 active ingredients and 202 effective targets were obtained from compound Xueshuantong capsules, involving 1539 RVO disease targets, ultimately, 115 effective targets of compound Xueshuantong capsules in the treatment of RVO, by PPI, ten core targets were selected, by enrichment analysis, the effective targets were mainly involved in cancer related pathway, diabetic complications related AGE-RAGE, fluid shear stress and atherosclerosis, IL-17, tumor necrosis factor, PI3K-Akt, and MAPK signaling pathways. ConclusionCompound Xueshuantong capsules could treat RVO mainly through regulating oxidative stress, inflammatory factors, neovascularity and cellular apoptosis.

相似文献/References:

[1]田琳,毕胜男,陈梦竹,等.基于网络药理学探索血府逐瘀汤治疗非小细胞肺癌的作用机制[J].西部中医药,2022,35(01):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
　TIAN Lin,BI Shengnan,CHEN Mengzhu,et al.Research on the Mechanism of Xuefu Zhuyu Decoction in the Treatment of NSCLC Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(01):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
[2]吴春凤,黄艳霞,郑景辉.基于网络药理学分析荆芥—防风药对的分子作用机制[J].西部中医药,2022,35(02):74.[doi:10.12174/j.issn.2096-9600.2022.02.18]
　WU Chunfeng,HUANG Yanxia,ZHENG Jinghui.Molecular Mechanism of Couplet Medicinals Jingjie‐Fangfeng Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(01):74.[doi:10.12174/j.issn.2096-9600.2022.02.18]
[3]陶鑫,薛中峰,覃骊兰.基于网络药理学的过敏煎治疗过敏性哮喘分子机制研究[J].西部中医药,2022,35(03):27.[doi:10.12174/j.issn.2096-9600.2022.03.07]
　TAO Xin,XUE Zhongfeng,QIN Lilan.Study on the Molecular Mechanism of Guomin Jian in the Treatment of Allergic Asthma Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(01):27.[doi:10.12174/j.issn.2096-9600.2022.03.07]
[4]黄康勤.基于网络药理学预测穿心莲内酯抗呼吸道感染的分子作用机制[J].西部中医药,2022,35(03):33.[doi:10.12174/j.issn.2096-9600.2022.03.08]
　HUANG Kangqin.Molecular Mechanism of Andrographolide against Respiratory Tract Infection Predicted by Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(01):33.[doi:10.12174/j.issn.2096-9600.2022.03.08]
[5]石威,张俊忠,解鹏超,等.基于网络药理学和分子对接探析淫羊藿-牛膝药对治疗股骨头坏死的作用机制[J].西部中医药,2022,35(04):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
　SHI Wei,ZHANG Junzhong,XIE Pengchao,et al.Study on the Mechanism of Yinyanghuo-Niuxi Drug Pair in Treating Femoral Head Necrosis Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2022,35(01):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
[6]刘卓超,黄小靖,曾志聪.黄连生物碱改善心力衰竭的网络药理学机制研究[J].西部中医药,2022,35(04):42.[doi:10.12174/j.issn.2096-9600.2022.04.10]
　LIU Zhuochao,HUANG Xiaojing,ZENG Zhicong.Study on the Mechanism of Coptis Alkaloid in the Treatment of Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(01):42.[doi:10.12174/j.issn.2096-9600.2022.04.10]
[7]张维芯,周青,戴国梁,等.基于SARS-CoV-2关键蛋白ACE2探索“葛根-柴胡”治疗COVID-19的潜在机制[J].西部中医药,2022,35(05):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
　ZHANG Weixin,ZHOU Qing,DAI Guoliang,et al.The Potential Mechanism of “Gegen-Chaihu” in the Treatment of COVID-19 Based on SARS-CoV-2 Target Protein ACE2[J].Western Journal of Traditional Chinese Medicine,2022,35(01):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
[8]林鑫,刘阳,陈林伟,等.基于网络药理学探讨气血双补方抗慢性心力衰竭的作用机制[J].西部中医药,2022,35(06):29.[doi:10.12174/j.issn.2096-9600.2022.06.08]
　LIN Xin,LIU Yang,CHEN Linwei,et al.Study on the Mechanism of Qixue Shuangbu Prescription in Treating Chronic Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(01):29.[doi:10.12174/j.issn.2096-9600.2022.06.08]
[9]潘威.基于网络药理学探讨大黄治疗溃疡性结肠炎的机制[J].西部中医药,2022,35(06):80.[doi:10.12174/j.issn.2096-9600.2022.06.21]
　PAN Wei.The Mechanism of Dahuang in Treating Ulcerative Colitis Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(01):80.[doi:10.12174/j.issn.2096-9600.2022.06.21]
[10]李磊,宁南义,王小龙,等.基于网络药理学的新型冠状病毒肺炎核心中药靶标预测及其作用机制研究?[J].西部中医药,2021,34(11):10.[doi:10.12174/j.issn.2096-9600.2021.11.03]
　LI Lei,NING Nanyi,WANG Xiaolong,et al.The Study on the Mechanism and Target Prediction of Core Herbs of COVID-19 Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2021,34(01):10.[doi:10.12174/j.issn.2096-9600.2021.11.03]

备注/Memo

备注/Memo:
陈雁君（1994—），女，硕士学位。研究方向：眼底病的中西医结合防治及中医五官科学。关国华全国名老中医药专家传承工作室（国中医药人教育便函〔2018〕74号）。
更新日期/Last Update: 2024-01-15